Once an individual is identified as being myopic, then the practitioner is required to provide a specific option would help their circumstance and, once the treatment begins, provide feedback on the progression of myopia and the performance of the treatment. Currently, the evidence for slowing progression of myopia with various optical, pharmaceutical and environmental strategies is substantial and there are a large and growing number of options from which to select an appropriate strategy. The rate at which myopia progresses with one or more of the myopia management strategies is monitored using either refractive error and/or axial length.
Which of these two measures is important?
The attached guideline presents in a simple fashion, the role for each of these two measures in diagnosing and monitoring the progression of myopia.